Resultados de procura - Rajkumar Venkatramani

  • Mostrando 1 - 17 Resultados de 17
Limitar resultados
  1. 1
    A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors

    A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors por Rajkumar Venkatramani, Marcio H. Malogolowkin, Tom B. Davidson, William May, Richard Sposto, Leo Mascarenhas

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017

    Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017 por Matthew T. McEvoy, David A. Siegel, Shifan Dai, M. Fatih Okcu, Mark Zobeck, Rajkumar Venkatramani, Philip J. Lupo

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

    An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials por Josephine H. HaDuong, Christine M. Heske, Wendy Allen‐Rhoades, Wei Xue, Lisa A. Teot, David A. Rodeberg, Sarah S. Donaldson, Aaron R. Weiss, Douglas S. Hawkins, Rajkumar Venkatramani

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials

    Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials por Sapna Oberoi, Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger, Kiran A Kumar, Kenneth Wong, Sarah S. Donaldson, Lisa A. Teot, Erin R. Rudzinski, Rajkumar Venkatramani

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors

    Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors por Saro H. Armenian, Sarah Gelehrter, Tabitha Vase, Rajkumar Venkatramani, Wendy Landier, Karla Wilson, Claudia Herrera, Leah Reichman, John-David Menteer, Leo Mascarenhas, David R. Freyer, Kalyanasundaram Venkataraman, Ravi Bhatia

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Advances in the clinical management of high‐risk Wilms tumors

    Advances in the clinical management of high‐risk Wilms tumors por Michael V. Ortiz, Christa Koenig, Amy E. Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M. C. Mavinkurve‐Groothuis, Thelma B. Velasquez Herrera, Rajkumar Venkatramani, Andrew D. Woods, Jeffrey S. Dome, Filippo Spreafico

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism

    NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism por Christopher A. French, Shaila Rahman, Erica M. Walsh, Simone Kühnle, Adlai R. Grayson, Madeleine E. Lemieux, Noam Grunfeld, Brian P. Rubin, Cristina R. Antonescu, Songlin Zhang, Rajkumar Venkatramani, Paola Dal Cin, Peter M. Howley

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

    Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature por Alissa Groenendijk, Filippo Spreafico, Ronald R. de Krijger, Jarno Drost, Jesper Brok, Daniela Perotti, Harm van Tinteren, Rajkumar Venkatramani, Jan Godziński, Christian Rübe, James I. Geller, Norbert Graf, Marry M. van den Heuvel‐Eibrink, Annelies M. C. Mavinkurve‐Groothuis

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

    Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group por Samuel Abbou, Kelly S. Klega, Junko Tsuji, Mohammad Tanhaemami, David Hall, Donald A. Barkauskas, Mark Krailo, Carrie Cibulskis, Anwesha Nag, Aaron R. Thorner, Samuel Pollock, Alma Imamović, Jack F. Shern, Steven G. DuBois, Rajkumar Venkatramani, Douglas S. Hawkins, Brian D. Crompton

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group

    Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group por Jacquelyn Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A.S. Arndt, Sarah S. Donaldson, Douglas J. Harrison, Douglas S. Hawkins, Corinne M. Linardic, Leo Mascarenhas, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Barry L. Shulkin, David Walterhouse, Rajkumar Venkatramani, Aaron R. Weiss

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

    Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis por Sarah Burkhead Whittle, Rajkumar Venkatramani, Anton Schönstein, Svetlana Pack, Rita Alaggio, Christian Vokuhl, Erin R. Rudzinski, Anna–Lena Wulf, Angelica Zin, Juliana R. Gruver, Michael Arnold, Johannes H. M. Merks, Simone Hettmer, Ewa Kościelniak, Frederic G. Barr, Douglas S. Hawkins, Gianni Bisogno, Monika Sparber‐Sauer

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial

    Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial por Rajkumar Venkatramani, Lingyun Ji, Joseph L. Lasky, Kelley Haley, Alexander R. Judkins, Shengmei Zhou, Richard Sposto, Randal Olshefski, James H. Garvin, Tanya Tekautz, Gloria A. Kennedy, Shahrad R. Rassekh, Theodore B. Moore, Sharon L. Gardner, Jeffrey C. Allen, Richard M. Shore, Christopher L. Moertel, Mark Atlas, Girish Dhall, Jonathan L. Finlay

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study

    Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study por Nathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker‐Nolting, Soledad Gallego, Franco Locatelli, Francisco Bautista, Alessandra Longhi, Cyril Lervat, Natacha Entz‐Werlé, Michela Casanova, Isabelle Aerts, Sandra J. Strauss, Estelle Thébaud, Bruce Morland, Adela Cañete, Perrine Marec‐Bérard, Marion Gambart, Claudia Rössig, Chinyere E. Okpara, Cixin He, Lea Dutta, Quentin Campbell‐Hewson

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

    Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆ por Nathalie Gaspar, Quentin Campbell‐Hewson, Soledad Gallego, Franco Locatelli, Rajkumar Venkatramani, Stefanie Hecker‐Nolting, Marion Gambart, Francisco Bautista, Estelle Thébaud, Isabelle Aerts, Bruce Morland, Claudia Rössig, Adela Cañete, Alessandra Longhi, Cyril Lervat, N. Entz-Werle, Sandra J. Strauss, Perrine Marec‐Bérard, Chinyere E. Okpara, Cixin He, Lea Dutta, Michela Casanova

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

    Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Chil... por Simone Hettmer, Corinne M. Linardic, Anna Kelsey, Erin R. Rudzinski, Christian Vokuhl, Joanna Selfe, Olivia Ruhen, Jack F. Shern, Javed Khan, Alexander R. Kovach, Philip J. Lupo, Susanne A. Gatz, Beat W. Schäfer, Samuel L. Volchenboum, Véronique Minard‐Colin, Ewa Kościelniak, Douglas S. Hawkins, Gianni Bisogno, Monika Sparber‐Sauer, Rajkumar Venkatramani, Johannes H. M. Merks, Janet Shipley

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

    Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma por Bailey A. Martin‐Giacalone, He Li, Michael E. Scheurer, Dana L. Casey, Shannon Dugan‐Perez, Deborah A. Marquez-Do, Donna M. Muzny, Richard A. Gibbs, Donald A. Barkauskas, David Hall, Douglas R. Stewart, Joshua D. Schiffman, Matthew T. McEvoy, Javed Khan, David Malkin, Corinne M. Linardic, Brian D. Crompton, Jack F. Shern, Stephen X. Skapek, Rajkumar Venkatramani, Douglas S. Hawkins, Aniko Sabo, Sharon E. Plon, Philip J. Lupo

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies por Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, Franca Ligas, Nick Bird, Teresa de Rojas, Zachary Zimmerman, Keith D. Wilner, Willi Woessmann, Susan Weiner, Brenda J. Weigel, Rajkumar Venkatramani, D Valteau, Toby N. Trahair, Malcolm A. Smith, Sonia Singh, Giovanni Selvaggi, Nicole Scobie, Gudrun Schleiermacher, Nicholas C. Richardson, Julie Park, Karsten Nysom, Koen Norga, Margret Merino, Joe McDonough, Yousif Matloub, Lynley V. Marshall, Eric Lowe, Giovanni Lesa, Meredith S. Irwin, Dominik Karres, Amar Gajjar, François Doz, Elizabeth Fox, Steven G. DuBois, Martha Donoghue, Michela Casanova, Hubert Caron, Victoria Buenger, Diana Bradford, P. Blanc, Amy Barone, Gregory H. Reaman, Gilles Vassal

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: